元隆雅圖(002878.SZ):正在研究利用多模態AIGC工具進一步提升AIGC模型的效能
格隆匯12月18日丨元隆雅圖(002878.SZ)在投資者互動平台表示,目前公司通過國家知識產權局發明專利初審的AIGC模型具備文本生成圖片的能力,經過預訓練,可使輸出圖片在內容豐富多樣的同時,保持風格的一致性和穩定性。該模型可為用户提供個性化創作工具,大幅提升內容生成和創作效率,能夠廣泛應用於企業品牌形象創作、IP衍生內容及產品創作、UGC數字藝術創作、用户社交創意玩法等多種場景,賦能企業品牌營銷、用户私域社羣運營、數實IP文創品開發、元宇宙場景開發、IP資產孵化變現及運營等多種業務。公司正在研究利用多模態AIGC工具進一步提升AIGC模型的效能。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.